Yasushi Hayashida
Ureshino, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens.
Journal: Archives of pathology & laboratory medicine
Published: June 07, 2023
Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer.
Journal: Urologic oncology
Published: April 18, 2023
ASO Author Reflections: Is T1HG Bladder Cancer a Good Candidate for En Bloc Resection?
Journal: Annals of surgical oncology
Published: February 14, 2023
En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis.
Journal: Annals of surgical oncology
Published: October 04, 2022
Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?
Journal: BJU international
Published: April 30, 2022
Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non-muscle-invasive bladder cancer: a randomised clinical trial.
Journal: BJU international
Published: June 18, 2021
A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer.
Journal: BMC urology
Published: July 02, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026